Sonstiges: |
- Nachgewiesen in: MEDLINE
- Sprachen: English
- Publication Type: Journal Article; Research Support, Non-U.S. Gov't
- Language: English
- [Mucosal Immunol] 2021 Mar; Vol. 14 (2), pp. 468-478. <i>Date of Electronic Publication: </i>2020 Aug 18.
- MeSH Terms: Asthma / *immunology ; Hypersensitivity / *immunology ; Inflammation / *immunology ; Interleukin-1 Receptor-Like 1 Protein / *metabolism ; Lymphocytes / *immunology ; PPAR gamma / *metabolism ; Respiratory System / *immunology ; Animals ; Cells, Cultured ; Cytokines / metabolism ; Gene Expression Regulation ; Humans ; Immunity, Innate ; Interleukin-1 Receptor-Like 1 Protein / genetics ; Mice ; Mice, Inbred C57BL ; Mice, Inbred NOD ; Mice, Knockout ; PPAR gamma / genetics ; Th2 Cells / immunology
- Comments: Comment in: Mucosal Immunol. 2021 May;14(3):544-546. (PMID: 33328594)
- References: Papi, A., Brightling, C., Pedersen, S. E. & Reddel, H. K. Asthma. Lancet 391, 783–800 (2018). (PMID: 29273246) ; Lambrecht, B. N. & Hammad, H. The immunology of asthma. Nat. Immunol. 16, 45–56 (2015). (PMID: 25521684) ; Divekar, R. & Kita, H. Recent advances in epithelium-derived cytokines (IL-33, IL-25, and thymic stromal lymphopoietin) and allergic inflammation. Curr. Opin. Allergy Clin. Immunol. 15, 98–103 (2015). (PMID: 254793134346181) ; Monticelli, L. A., Sonnenberg, G. F. & Artis, D. Innate lymphoid cells: critical regulators of allergic inflammation and tissue repair in the lung. Curr. Opin. Immunol. 24, 284–289 (2012). (PMID: 225211393383398) ; Halim, T. Y. et al. Group 2 innate lymphoid cells are critical for the initiation of adaptive T helper 2 cell-mediated allergic lung inflammation. Immunity 40, 425–435 (2014). (PMID: 246130914210641) ; Mirchandani, A. S. et al. Type 2 innate lymphoid cells drive CD4+ Th2 cell responses. J. Immunol. 192, 2442–2448 (2014). (PMID: 24470502) ; Lei, A. H. et al. ICAM-1 controls development and function of ILC2. J. Exp. Med. 215, 2157–2174 (2018). (PMID: 300497046080904) ; Serafini, N., Vosshenrich, C. A. & Di Santo, J. P. Transcriptional regulation of innate lymphoid cell fate. Nat. Rev. Immunol. 15, 415–428 (2015). (PMID: 26065585) ; Gasteiger, G., Fan, X., Dikiy, S., Lee, S. Y. & Rudensky, A. Y. Tissue residency of innate lymphoid cells in lymphoid and nonlymphoid organs. Science 350, 981–985 (2015). (PMID: 264727624720139) ; Walker, J. A., Barlow, J. L. & McKenzie, A. N. J. Innate lymphoid cells—how did we miss them? Nat. Rev. Immunol. 13, 75–87 (2013). (PMID: 23292121) ; Kabata, H., Moro, K. & Koyasu, S. The group 2 innate lymphoid cell (ILC2) regulatory network and its underlying mechanisms. Immunol. Rev. 286, 37–52 (2018). (PMID: 30294963) ; Brestoff, J. R. et al. Group 2 innate lymphoid cells promote beiging of white adipose tissue and limit obesity. Nature 519, 242–246 (2015). (PMID: 25533952) ; Monticelli, L. A. et al. Innate lymphoid cells promote lung-tissue homeostasis after infection with influenza virus. Nat. Immunol. 12, 1045–1054 (2011). (PMID: 219464173320042) ; Vivier, E. et al. Innate lymphoid cells: 10 years on. Cell 174, 1054–1066 (2018). (PMID: 30142344) ; Hurrell, B. P., Shafiei Jahani, P. & Akbari, O. Social networking of group two innate lymphoid cells in allergy and asthma. Front. Immunol. 9, 2694 (2018). (PMID: 305244376256740) ; Hoyler, T. et al. The transcription factor GATA-3 controls cell fate and maintenance of type 2 innate lymphoid cells. Immunity 37, 634–648 (2012). (PMID: 230633333662874) ; Mjosberg, J. et al. The transcription factor GATA3 is essential for the function of human type 2 innate lymphoid cells. Immunity 37, 649–659 (2012). (PMID: 23063330) ; Clark, R. B. The role of PPARs in inflammation and immunity. J. Leukoc. Biol. 71, 388–400 (2002). (PMID: 11867676) ; Ahmadian, M. et al. PPARgamma signaling and metabolism: the good, the bad and the future. Nat. Med. 19, 557–566 (2013). (PMID: 23652116) ; Tontonoz, P., Hu, E. & Spiegelman, B. M. Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor. Cell 79, 1147–1156 (1994). (PMID: 8001151) ; Daynes, R. A. & Jones, D. C. Emerging roles of PPARs in inflammation and immunity. Nat. Rev. Immunol. 2, 748–759 (2002). (PMID: 12360213) ; Honda, K., Marquillies, P., Capron, M. & Dombrowicz, D. Peroxisome proliferator-activated receptor gamma is expressed in airways and inhibits features of airway remodeling in a mouse asthma model. J. Allergy Clin. Immunol. 113, 882–888 (2004). (PMID: 15131570) ; Benayoun, L. et al. Regulation of peroxisome proliferator-activated receptor gamma expression in human asthmatic airways: relationship with proliferation, apoptosis, and airway remodeling. Am. J. Respir. Crit. Care Med. 164, 1487–1494 (2001). (PMID: 11704601) ; Li, W. et al. Association of peroxisome proliferator-activated receptor-gamma gene polymorphisms and gene–gene interaction with asthma risk in a Chinese adults population. Int. J. Clin. Exp. Med. 8, 19346–19352 (2015). (PMID: 267705744694474) ; Zhang, Y., Wang, Z. & Ma, T. Associations of genetic polymorphisms relevant to metabolic pathway of vitamin D3 with development and prognosis of childhood bronchial asthma. DNA Cell Biol. 36, 682–692 (2017). (PMID: 28590769) ; Spears, M. et al. Bronchodilatory effect of the PPAR-gamma agonist rosiglitazone in smokers with asthma. Clin. Pharm. Ther. 86, 49–53 (2009). ; Banno, A., Reddy, A. T., Lakshmi, S. P. & Reddy, R. C. PPARs: key regulators of airway inflammation and potential therapeutic targets in asthma. Nucl. Receptor Res. 5, 101306 (2018). (PMID: 29450204) ; Narala, V. R. et al. Pioglitazone is as effective as dexamethasone in a cockroach allergen-induced murine model of asthma. Respir. Res. 8, 90 (2007). (PMID: 180532202231357) ; Lee, S. Y. et al. Peroxisome proliferator-activated receptor-gamma inhibits cigarette smoke solution-induced mucin production in human airway epithelial (NCI-H292) cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 291, L84–L90 (2006). (PMID: 16443643) ; Schneider, C. et al. Alveolar macrophages are essential for protection from respiratory failure and associated morbidity following influenza virus infection. PLoS Pathog. 10, e1004053 (2014). (PMID: 246996793974877) ; Hammad, H. et al. Activation of peroxisome proliferator-activated receptor-gamma in dendritic cells inhibits the development of eosinophilic airway inflammation in a mouse model of asthma. Am. J. Pathol. 164, 263–271 (2004). (PMID: 146953391602239) ; Nobs, S. P. et al. PPARgamma in dendritic cells and T cells drives pathogenic type-2 effector responses in lung inflammation. J. Exp. Med. 214, 3015–3035 (2017). (PMID: 287980295626395) ; Chen, T. et al. PPAR-γ promotes type 2 immune responses in allergy and nematode infection. Sci. Immunol. 2, pii: eaal5196 (2017). ; Pokrovskii, M. et al. Characterization of transcriptional regulatory networks that promote and restrict identities and functions of intestinal innate lymphoid cells. Immunity 51, 185–197. e186 (2019). (PMID: 312780586863506) ; Karagiannis, F. et al. Lipid-droplet formation drives pathogenic group 2 innate lymphoid cells in airway inflammation. Immunity 52, 620–634. e626 (2020). (PMID: 32268121) ; Taylor, S. et al. PD-1 regulates KLRG1(+) group 2 innate lymphoid cells. J. Exp. Med. 214, 1663–1678 (2017). (PMID: 284904415461001) ; Batyrova, B. et al. PD-1 expression affects cytokine production by ILC2 and is influenced by peroxisome proliferator-activated receptor-gamma. Immun. Inflamm. Dis. 8, 8–23 (2020). (PMID: 31742928) ; Robinette, M. L. et al. Transcriptional programs define molecular characteristics of innate lymphoid cell classes and subsets. Nat. Immunol. 16, 306–317 (2015). (PMID: 256218254372143) ; Ricote, M. et al. Expression of the peroxisome proliferator-activated receptor gamma (PPARgamma) in human atherosclerosis and regulation in macrophages by colony stimulating factors and oxidized low density lipoprotein. Proc. Natl Acad. Sci. USA 95, 7614–7619 (1998). (PMID: 9636198) ; Salimi, M. et al. A role for IL-25 and IL-33-driven type-2 innate lymphoid cells in atopic dermatitis. J. Exp. Med. 210, 2939–2950 (2013). (PMID: 243233573865470) ; Hazenberg, M. D. & Spits, H. Human innate lymphoid cells. Blood 124, 700–709 (2014). (PMID: 24778151) ; Huang, Y. et al. IL-25-responsive, lineage-negative KLRG1(hi) cells are multipotential ‘inflammatory’ type 2 innate lymphoid cells. Nat. Immunol. 16, 161–169 (2015). (PMID: 25531830) ; Abt, M. C. et al. Innate immune defenses mediated by two ILC subsets are critical for protection against acute clostridium difficile infection. Cell Host Microbe 18, 27–37 (2015). (PMID: 261597184537644) ; Satoh-Takayama, N. et al. The chemokine receptor CXCR6 controls the functional topography of interleukin-22 producing intestinal innate lymphoid cells. Immunity 41, 776–788 (2014). (PMID: 25456160) ; Ebbo, M., Crinier, A., Vely, F. & Vivier, E. Innate lymphoid cells: major players in inflammatory diseases. Nat. Rev. Immunol. 17, 665–678 (2017). (PMID: 28804130) ; Li, B. W. et al. T cells are necessary for ILC2 activation in house dust mite-induced allergic airway inflammation in mice. Eur. J. Immunol. 46, 1392–1403 (2016). (PMID: 27062360) ; Liu, B., Lee, J. B., Chen, C. Y., Hershey, G. K. & Wang, Y. H. Collaborative interactions between type 2 innate lymphoid cells and antigen-specific CD4+ Th2 cells exacerbate murine allergic airway diseases with prominent eosinophilia. J. Immunol. 194, 3583–3593 (2015). (PMID: 257800464390517) ; Moriyama, S. et al. beta2-adrenergic receptor-mediated negative regulation of group 2 innate lymphoid cell responses. Science 359, 1056–1061 (2018). (PMID: 29496881) ; Guan, H. P., Ishizuka, T., Chui, P. C., Lehrke, M. & Lazar, M. A. Corepressors selectively control the transcriptional activity of PPARgamma in adipocytes. Genes Dev. 19, 453–461 (2005). (PMID: 15681609548946) ; Matsusue, K. et al. Hepatic steatosis in leptin-deficient mice is promoted by the PPARgamma target gene Fsp27. Cell Metab. 7, 302–311 (2008). (PMID: 183961362587176) ; Anderson, J. R. et al. Evaluation of the PPAR-gamma agonist pioglitazone in mild asthma: a double-blind randomized controlled trial. PLoS ONE 11, e0160257 (2016). (PMID: 275601684999189) ; Kaler, M. et al. A randomized, placebo-controlled, double-blinded, crossover trial of pioglitazone for severe asthma. J. Allergy Clin. Immunol. 140, 1716–1718 (2017). (PMID: 286258065723231) ; Richards, D. B., Bareille, P., Lindo, E. L., Quinn, D. & Farrow, S. N. Treatment with a peroxisomal proliferator activated receptor gamma agonist has a modest effect in the allergen challenge model in asthma: a randomised controlled trial. Respir. Med. 104, 668–674 (2010). (PMID: 19944580) ; Wilhelm, C. et al. Critical role of fatty acid metabolism in ILC2-mediated barrier protection during malnutrition and helminth infection. J. Exp. Med. 213, 1409–1418 (2016). (PMID: 274329384986525) ; Poulsen, L., Siersbaek, M. & Mandrup, S. PPARs: fatty acid sensors controlling metabolism. Semin. Cell Dev. Biol. 23, 631–639 (2012). (PMID: 22273692) ; Lee, M. W. et al. Activated type 2 innate lymphoid cells regulate beige fat biogenesis. Cell 160, 74–87 (2015). (PMID: 25543153) ; Maazi, H. et al. ICOS:ICOS-ligand interaction is required for type 2 innate lymphoid cell function, homeostasis, and induction of airway hyperreactivity. Immunity 42, 538–551 (2015). (PMID: 257696134366271) ; Monticelli, L. A. et al. Arginase 1 is an innate lymphoid-cell-intrinsic metabolic checkpoint controlling type 2 inflammation. Nat. Immunol. 17, 656–665 (2016). (PMID: 270434094873382) ; Qin, A. et al. Expansion of monocytic myeloid-derived suppressor cells dampens T cell function in HIV-1-seropositive individuals. J. Virol. 87, 1477–1490 (2013). (PMID: 231525363554138) ; Wan, J. et al. Pioglitazone modulates the proliferation and apoptosis of vascular smooth muscle cells via peroxisome proliferators-activated receptor-gamma. Diabetol. Metab. Syndr. 6, 101 (2014). (PMID: 253020794190377) ; Whiteside, C. et al. Rosiglitazone prevents high glucose-induced vascular endothelial growth factor and collagen IV expression in cultured mesangial cells. Exp. Diabetes Res. 2009, 910783 (2009). (PMID: 196094562709725)
- Substance Nomenclature: 0 (Cytokines) ; 0 (Il1rl1 protein, mouse) ; 0 (Interleukin-1 Receptor-Like 1 Protein) ; 0 (PPAR gamma)
- Entry Date(s): Date Created: 20200820 Date Completed: 20211129 Latest Revision: 20230203
- Update Code: 20240513
|